Intelicare Holdings Limited (ASX:ICR)
0.0260
-0.0010 (-3.70%)
Sep 4, 2026, 2:00 PM AEST
Intelicare Holdings Revenue
In the fiscal year ending June 30, 2026, Intelicare Holdings had annual revenue of 2.04M AUD with 113.42% growth. Intelicare Holdings had revenue of 1.55M in the half year ending June 30, 2026, with 861.36% growth.
Revenue
2.04M
Revenue Growth
+113.42%
P/S Ratio
9.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.04M | 1.09M | 113.42% |
| Jun 30, 2025 | 956.74K | 672.63K | 236.75% |
| Jun 30, 2024 | 284.11K | -126.10K | -30.74% |
| Jun 30, 2023 | 410.21K | -77.11K | -15.82% |
| Jun 30, 2022 | 487.32K | 115.11K | 30.92% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Doctor Care Anywhere Group | 75.18M |
| Adheris Health | 33.96M |
| Beamtree Holdings | 29.19M |
| Resonance Health | 15.75M |
| Pharmx Technologies | 7.62M |
| Careteq | 6.08M |
| Vitasora Health | 4.84M |
| Emyria | 4.05M |